EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Antibiogram and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae in a Nigerian Teaching Hospital

Olabisi Promise Lawal, Joshua Odunayo Babatunde, Sandra Owusu-Ansah, Chinaemerem Precious Ani, Abiodun Christopher Adegbesan, Hajara Hashim, Jenifer Chiagozie Okeke, Nyerovwo Charity Okei, Aimuanmwosa Andrew Igunma, Daniel Osezuwa Ubebe, Kingsley Ugonna Ugoagwu, Okabeonye Sunday Agbo, Charissa Favour Ani

Microbes, Infection and Chemotherapy · 2025-03-24 · 5 · e2305

DOI: 10.54034/mic.e2305 ↗
AbstractBibliografische Angaben

Abstract

Background: Klebsiella pneumoniae is a gram-negative bacterium responsible for infections like urinary tract infections (UTIs) and is a leading cause of nosocomial infections in immunocompromised patients. Data on resistance profiles in Nigeria is limited. This study investigated the antibiogram and molecular characteristics of ESBL-producing Klebsiella pneumoniae at the University of Medical Sciences Teaching Hospital, Ondo State. Methods: A cross-sectional study analyzed 300 samples from urine, sputum, and wound infections. Isolates were cultured on MacConkey agar, followed by biochemical tests. The Kirby-Bauer method assessed resistance, and the double-disk synergy test confirmed ESBL production. PCR identified blaTEM, blaSHV, and blaCTX-M genes. SPSS was used for statistical analysis (P < 0.05). Results: Of 300 samples, 185 showed bacterial growth, with 54 confirmed as Klebsiella pneumoniae. Among these, 22 were multidrug-resistant (MDR), and 8 (14.8%) were ESBL producers. The blaTEM gene was present in all ESBL isolates, and the blaSHV gene in 7 of 8 (87.5%). Resistance to β-lactam antibiotics and aminoglycosides was high. Older patients and prolonged hospital stays correlated with higher MDR rates. A slight female predominance was noted. Conclusions: The high prevalence of MDR Klebsiella pneumoniae highlights the need for enhanced surveillance and deeper understanding of resistance patterns in the region.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →